Cellular Proliferation of Equine Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem Cells Decline With Increasing Donor Age

Background: Bone marrow (BM)- and adipose tissue (AT)-derived mesenchymal stem cells (MSCs) are used increasingly for autologous cell therapy in equine practice to treat musculoskeletal and other injuries. Current recommendations often call for 10–100 million MSCs per treatment, necessitating the ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagge, Jasmin, MacLeod, James N., Berg, Lise C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758322/
https://www.ncbi.nlm.nih.gov/pubmed/33363241
http://dx.doi.org/10.3389/fvets.2020.602403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758322/
https://www.ncbi.nlm.nih.gov/pubmed/33363241
http://dx.doi.org/10.3389/fvets.2020.602403

Ejemplares similares